Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

N Bruckl; R Wirtz; E Veltrup; Christian Meyer; G Zeitler; D Wuerflein; Fabian Reich; Joachim H. Ficker; S Eidt; W Bruckl

Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

N Bruckl, R Wirtz, E Veltrup, Christian Meyer, G Zeitler, D Wuerflein, Fabian Reich, Joachim H. Ficker, S Eidt, W Bruckl

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	148-148
Fachzeitschrift	Oncology Research and Treatment
Jahrgang	45
Ausgabenummer	SUPPL 3
Publikationsstatus	Veröffentlicht - 2022

Dieses zitieren

Bruckl, N., Wirtz, R., Veltrup, E., Meyer, C., Zeitler, G., Wuerflein, D., Reich, F., Ficker, J. H., Eidt, S., & Bruckl, W. (2022). Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC). Oncology Research and Treatment, 45(SUPPL 3), 148-148.

@article{241d524677e646009487373b4a0ea9f4,

title = "Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)",

author = "N Bruckl and R Wirtz and E Veltrup and Christian Meyer and G Zeitler and D Wuerflein and Fabian Reich and Ficker, {Joachim H.} and S Eidt and W Bruckl",

year = "2022",

language = "English",

volume = "45",

pages = "148--148",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

number = "SUPPL 3",

}

Bruckl, N, Wirtz, R, Veltrup, E, Meyer, C, Zeitler, G, Wuerflein, D, Reich, F , Ficker, JH, Eidt, S & Bruckl, W 2022, 'Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)', Oncology Research and Treatment, Jg. 45, Nr. SUPPL 3, S. 148-148.

Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC). / Bruckl, N; Wirtz, R; Veltrup, E et al.
in: Oncology Research and Treatment, Jahrgang 45, Nr. SUPPL 3, 2022, S. 148-148.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

AU - Bruckl, N

AU - Wirtz, R

AU - Veltrup, E

AU - Meyer, Christian

AU - Zeitler, G

AU - Wuerflein, D

AU - Reich, Fabian

AU - Ficker, Joachim H.

AU - Eidt, S

AU - Bruckl, W

PY - 2022

Y1 - 2022

M3 - Abstract (Journal)

SN - 2296-5270

VL - 45

SP - 148

EP - 148

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

IS - SUPPL 3

ER -